We found that, in both the murine glioma and squamous cell carcinoma models, the combined treatment of oHSV T3855 with HDACi showed significant inhibition of tumor progression, which may be due to increased virus replication (Figure S3) and upregulated PD-L1 expression, as we determined in vitro. The gene discussed is CD274; the disease is central nervous system cancer.